Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NeuroPace (NPCE)
NASDAQ:NPCE
Holding NPCE?
Track your performance easily
Earnings Data
Report Date
Mar 05, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.24Last Year’s EPS
-0.23Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 10, 2021
|% Change Since: 67.65%
|Next Earnings Date:Aug 12, 2021
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with strong revenue growth, strategic leadership hires, and successful programs like Project CARE contributing to growth. Although there are some challenges such as slightly decreased gross margins and increased operating expenses, the company demonstrated financial discipline and improved its cash position.Company Guidance
During the NeuroPace third quarter 2024 earnings call, the company provided updated guidance reflecting strong performance and future expectations. NeuroPace reported a total revenue of $21.1 million for Q3 2024, a 28% increase year-over-year, driven largely by sales of the RNS system, with a significant contribution from DIXI Medical products. The company improved its cash position to $56.8 million, reducing cash burn to $1.8 million for the quarter. Operating expenses were $19.7 million, up 8% from the previous year, with R&D expenses increasing to $5.8 million. Looking ahead, NeuroPace projects total revenue for 2024 in the range of $78 million to $80 million, representing a 19% to 22% growth over 2023, and expects gross margins to remain between 72% to 74%. Operating expenses for 2024 are anticipated to be between $80 million and $84 million, including approximately $10 million in non-cash stock-based compensation. The company highlighted its multiphase growth strategy, including expansion of the Project CARE program and preparation for potential new indications for the RNS system.Record Revenue Growth
NeuroPace reported total revenue of $21.1 million for Q3 2024, an increase of 28% compared to the same period last year. Revenue growth was primarily driven by increased sales of the RNS system.
Improved Cash Position
The company's cash balance increased from $55.5 million at the end of Q2 to $56.8 million at the end of Q3, with a reduced cash burn of $1.8 million for the quarter.
Strategic Leadership Hires
NeuroPace announced the hiring of new senior leaders, including Katie Keller, Brett Wingeier, and Amy Treadwell, to bolster marketing, R&D, and HR functions.
Project CARE Pilot Success
The Project CARE pilot program showed meaningful contributions to revenue growth, with increased implants and referrals from participating centers.
---
NPCE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NPCE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | $7.14 | $9.15 | +28.15% |
| Aug 13, 2024 | $7.28 | $6.77 | -7.01% |
| May 08, 2024 | $12.60 | $7.97 | -36.75% |
| Mar 05, 2024 | $14.20 | $13.98 | -1.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does NeuroPace (NPCE) report earnings?
NeuroPace (NPCE) is schdueled to report earning on Mar 05, 2025, TBA Not Confirmed.
What is NeuroPace (NPCE) earnings time?
NeuroPace (NPCE) earnings time is at Mar 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NPCE EPS forecast?
NPCE EPS forecast for the fiscal quarter 2024 (Q4) is -0.24.
---